DRKS00032747
Recruiting
Not Applicable
Clinical and structural outcome after pediatric injury of anterior cruciate ligament - Pediatric cruciate ligament injuries
BG Klinikum Duisburg0 sites100 target enrollmentSeptember 25, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- S83.53
- Sponsor
- BG Klinikum Duisburg
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Surgically treated intraligamentous injury or bony avulsion of the anterior cruciate ligament from the eminentia intercondylaris (eminentia fractures Meyers /McKeever II \- IV)
- •\- Maximum 17 years old at the time of injury
- •\- Open growth plates
- •\- Cruciate ligament surgery at least 24 months ago
Exclusion Criteria
- •\- Missing Declaration of consent and rejection of study\-participation by patient, parent or legal guardian
- •\- Patients who are not able to consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical Characteristics and Outcomes of Pediatric Osteosarcoma in ThailandPediatric OsteosarcomaOsteosarcomaPediatricAmputationLimb salvageChemotherapyMethotrexateTCTR20190812001Office of Research and Development, Phramongkutklao Hospital and College of Medicine29
Recruiting
Not Applicable
Clinical, structural and functional outcome after pediatric injury of anterior cruciate ligamentS83.53M23.51S82.18DRKS00031396BG Klinikum Duisburg gGmbH100
Recruiting
Not Applicable
A Comparative clinical outcome study of Children with Severe Pneumonia at KCMH and ASIAN PICU(PACCMAN)severe pneumonia in childrenTCTR20210929008/A100
Recruiting
Not Applicable
Kerosene poisoning in ChildreHealth Condition 1: null- Children below 5 years admitted with Kerosene consumptionCTRI/2014/08/004813Father Muller Medical College50
Not yet recruiting
Not Applicable
Clinical Outcomes of Treatment in Pediatric Medulloblastoma Based on Molecular Subgroup: A Single-center Experience.MedulloblastomaMolecular Subgroupoverall survivalTCTR20200825004Ratchadapiseksompotch Fund,Faculty of Medicine, Chulalongkorn university60